Terms ending in 2039
Every in-force patent on Nevro Corp.'s record whose computed term ends in 2039, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,123,565 | Treatment of Neurodegenerative Disease with High Frequency Stimulation, and Associated Systems and Methods In force · Medium confidence | Nevro Corp. | In force | Medium confidence | |
| US 10,933,238 | Power Control Circuit for Sterilized Devices, and Associated Systems and Methods In force · High confidence | Nevro Corp. | In force | High confidence | |
| US 10,799,701 | Systems and Methods for Identifying and Treating Patients with High-Frequency Electrical Signals In force · High confidence | Nevro Corp. | In force | High confidence | |
| US 11,534,611 | Therapeutic Modulation to Treat Blood Glucose Abnormalities, Including Type 2 Diabetes, And/Or Reduce HBA1C Levels, and Associated Systems and Methods In force · High confidence | Nevro Corp. | In force | High confidence | |
| US 11,571,570 | Power Control Circuit for Sterilized Devices, and Associated Systems and Methods In force · High confidence | Nevro Corp. | In force | High confidence | |
| US 11,684,786 | 2.4 GHZ Radio Antenna for Implanted Medical Devices, and Associated Systems and Methods In force · Medium confidence | Nevro Corp. | In force | Medium confidence |
6 of 6 patents shown. Soonest term end first, then patent number.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.